Back to search

Article

PLEK2 promotes lung adenocarcinoma progression via activating the PI3K/AKT signaling pathway through SPC25 Running title: PLEK2 promotes LUAD via SPC25/PI3K/AKT axis

2023-09-22

Abstract excerpt

Lung adenocarcinoma (LUAD) is the most common form of NSCLC with poor outcomes and late diagnosis. Previous studies have demonstrated the abnormal expression and promoting role of Pleckstrin-2 (PLEK2) in several tumor types including LUAD, the molecular mechanism of PLEK2 to LUAD progression has not been elucidated clearly. In this study, the expression of PLEK2 in LUAD was analyzed using public available the Canc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
720a720d-22f5-5587-b6fb-8c5b5fa22bb6
DOI
10.21203/rs.3.rs-3358328/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PLEK2 promotes lung adenocarcinoma progression via activating the PI3K/AKT signaling pathway through SPC25 Running title: PLEK2 promotes LUAD via SPC25/PI3K/AKT axisDOI 10.21203/rs.3.rs-3358328/v1
Select a neighboring publication to make it the new centre.